Efficacy of Bacillus clausii as an adjuvant therapy in pathological neonatal unconjugated hyperbilirubinemia in the Nile Delta region of Egypt: a randomized controlled trial.
- 2026-06-11
- RCT · n = 22
- Journal of tropical pediatrics 72(4)
- Samah S M Hussein
- Sahar M El-Haggar
- Sahar K Hegazy
- Mohamed A Rowisha
- PubMed: 42378553
- DOI: 10.1093/tropej/fmag047
- High evidence
- Clinical
Hospital stay was significantly shorter with probiotic therapy (3.8 ± 1.18 vs 6.3 ± 2.14 days; P < .001)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes